![](https://investorshub.advfn.com/uicon/441924.png?cb=1545404645)
Friday, January 02, 2015 7:10:48 PM
Hargrove told me that they were rethinking the way they will release info and I still believe this quarter will be a tell tail sign of how this will be dealt with until marketing approval occurs.
Based on the fact that there is a milestone to be hit this quarter regarding the prototype I expect and anticipate that the stock will trade up on anticipation of this and it better be on time in my opinion.
I've been doing this for 30 years I'm not a medical profession but an Wall Street guy turned trader/investor.
I realize you know a lot about medicine and the operating room but I have greater experience when it comes to his type of thing.
Also those that did the secondary will be looking for a return on their 37mm and thus far they are down and Hargrove will have to answer to them for sure.
My point was in fact similar to yours, if you can't stand the heat get out of the kitchen, so based on this the so called "real deal" needs to fly.
Great weekend and we will prevail and make huge gains with this one.
Believe that!
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM